Conference report--dendritic cells: myths and reality highlights from the annual meeting of the American Society for Cell Biology; December 13-17, 2003; San Francisco, California.

T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature (2004) 11.14

Dendritic cells: specialized and regulated antigen processing machines. Cell (2001) 10.44

Homing and cellular traffic in lymph nodes. Nat Rev Immunol (2003) 7.23

Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science (2003) 6.22

Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci (2000) 5.57

Progressive differentiation and selection of the fittest in the immune response. Nat Rev Immunol (2002) 4.17

Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol (2002) 3.78

Activation of lysosomal function during dendritic cell maturation. Science (2003) 3.22

Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature (2002) 3.21

The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol (2003) 3.06

The interaction of immunodeficiency viruses with dendritic cells. Curr Top Microbiol Immunol (2003) 1.79

Dynamics of cell surface molecules during T cell recognition. Annu Rev Biochem (2003) 1.46

Travellers in many guises: the origins and destinations of dendritic cells. Immunol Cell Biol (2002) 1.38

Immunology. T cell activation in six dimensions. Science (2002) 1.15

Immunodeficiency virus exploitation of dendritic cells in the early steps of infection. J Leukoc Biol (2003) 1.04

From the antigen-presenting cell to the antigen-presenting vesicle: the exosomes. Curr Opin Mol Ther (2002) 0.92

Anti-tumour immunotherapy using dendritic-cell-derived exosomes. Res Immunol (1999) 0.92

The actin-binding domain of spinophilin is necessary and sufficient for targeting to dendritic spines. Neuromolecular Med (2002) 0.89

DC-SIGN points the way to a novel mechanism for HIV-1 transmission. MedGenMed (2003) 0.82

Neuroethics: how to leave the cave without going astray: highlights from the Annual Meeting of the American Society of Neuroscience; November 8-12, 2003; New Orleans, Louisiana. MedGenMed (2003) 0.92

Genes and autoimmune diseases - a complex inheritance. MedGenMed (2004) 0.83

Anti-angiogenesis: the challenges ahead. MedGenMed (2003) 0.80

MedGenMed Hematology/Oncology conference report--plenary session: from genes to cells to metastasis. Highlights from the 2003 annual meeting of the American Association for Cancer Research. MedGenMed (2003) 0.78

Antiangiogenesis cocktails - stirred or shaken? MedGenMed (2004) 0.76

Progress in human genetics. MedGenMed (2004) 0.75

Amyloid, tau, and cell death in Alzheimer's disease. MedGenMed (2004) 0.75

Conference report--genomics: the promise of SNPs and bats highlights of the ABRF 2004--integrating technologies in proteomics and genomics; February 28-March 2, 2004; Portland, Oregon. MedGenMed (2004) 0.75

Conference report--cancer research 2004--top of the class March 27-March 31, 2004; Orlando, Florida. MedGenMed (2004) 0.75

Conference report--early cancer diagnosis: beating the odds. MedGenMed (2004) 0.75

Conference report--gene therapy and lung cancer--no time to wait. MedGenMed (2004) 0.75

Conference report--stem cells and neurologic repair: highlights from the annual meeting of the American Society of Neuroscience; November 8-12, 2003; New Orleans, Louisiana. MedGenMed (2004) 0.75

Conference report--extracellular matrix and cancer: revisiting metalloproteinases highlights from the annual meeting of the American Society for Cell Biology; December 13-17, 2003; San Francisco, California. MedGenMed (2004) 0.75

Conference report--structural genomics: parsing the architecture of proteins highlights of the ABRF 2004--integrating technologies in proteomics and genomics, February 28-March 2, 2004; Portland, Oregon. MedGenMed (2004) 0.75

ApoE and Alzheimer's disease--10 years later. MedGenMed (2004) 0.75

Conference report - transfusions and TRALI: what are the risks today? Highlights from the 71st Annual Meeting of the American Society for Clinical Laboratory Science; July 22-26, 2003; Philadelphia, Pennsylvania. MedGenMed (2003) 0.75

Functional genomics: improving cancer prognosis and drug development. MedGenMed (2003) 0.75

Conference report - magic markers for the diagnosis of thyroid carcinomas? Highlights from the Annual Meeting of the American Society of Clinical Pathology; September 18-21, 2003; New Orleans, Louisiana. MedGenMed (2003) 0.75

Spongiform encephalopathies: a tale of cannibals, cattle, and prions. MedGenMed (2003) 0.75

Functional genomics: a holistic approach. MedGenMed (2003) 0.75

Conference report - apoptosis - a graceful death: highlights from the 2003 Annual Meeting of the American Association for Cancer Research; July 11-14, 2003; Washington, DC. MedGenMed (2003) 0.75

MedGenMed Hematology/Oncology conference report--translational research: any danger lurking in its wake? Highlights from the 2003 annual meeting of the American Association for Cancer Research; July 11-14, 2003; Washington, DC. MedGenMed (2003) 0.75

Severe immunodeficiencies: bone marrow transplantation or gene therapy? MedGenMed (2003) 0.75

Conference report - clinical pathology: the top 5 studies in the journal: highlights from the Annual Meeting of the American Society of Clinical Pathology; September 18-21, 2003; New Orleans, Louisiana. MedGenMed (2003) 0.75

Stem cells: dreams or reality? MedGenMed (2003) 0.75

Cancer and the immune response: improving the odds. MedGenMed (2003) 0.75

Stem cells: a plenary policy forum. MedGenMed (2003) 0.75

Clinical proteomics: new promises for early cancer detection. MedGenMed (2003) 0.75

Targeting cancer cells -- more pathways, more inhibitors, more trails. Highlights of 9th annual Drug Discovery Technology World Congress; August 8-13, 2004; Boston, Massachusetts. MedGenMed (2004) 0.75

MedGenMed hematology/oncology conference report--dangerous liaisons: infections and cancer--time for a break-up? Highlights from the 2003 annual meeting of the American Association for Cancer Research; July 11-14, 2003; Washington, DC. MedGenMed (2003) 0.75

Conference report - breast cancer markers: what next? Highlights from the Annual Meeting of the American Society of Clinical Pathology; September 18-21, 2003; New Orleans, Louisiana. MedGenMed (2003) 0.75

Biodefense research: new tricks to fight old enemies. MedGenMed (2003) 0.75

Breast cancer: prevention, prediction, and treatment. MedGenMed (2003) 0.75